Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers)

American Journal of Cardiology

Volumn 80, Issue 4, 1997, Pages 469-474

  White, William B ^a,b,c   Mehrotra, Devan V ^a,b,c   Black, Henry R ^a,b,c   Fakouhi, T Daniel ^a,b,c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CONFOUNDING FACTORS (EPIDEMIOLOGY); DELAYED-ACTION PREPARATIONS; DIASTOLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SYSTOLE; TREATMENT OUTCOME; VERAPAMIL;

EID: 0030848602     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00397-4     Document Type: Article

References (18)

1. Pickering TG, Kaplan NM, Krakoff L, Prisant LM, Sheps S, Weber MA, White WB. American Society of Hypertension Expert Panel: Conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens. 9:1996;1-11.
2. White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens. 9:1996;29S-33S.
3. Weber MA, Cheung DG, Graettinger WF, Lipson JL. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. JAMA. 159:1988;3281-3285.
4. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 81:1990;700-702.
5. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 81:1990;528-536.
6. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension. 16:1990;692-699.
7. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 24:1994;793-801.
8. White WB, Anders RJ, MacIntyre JM, Black HR, Sica DA. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol. 76:1995;375-380.
9. White WB. Methods of blood pressure determination to assess antihypertensive agents: are casual measurements enough? Clin Pharmacol Ther. 45:1989;581-586.
10. Johnstone MT, Mittleman M, Tofler G, Muller JE. The pathophysiology of the onset of morning cardiovascular events. Am J Hypertens. 9:1996;22S-28S.
11. Cutler NR, Anders RJ, Jhee SS, Sramek JJ, Awan NA, Bultas J, Lahiri A, Woroszylska M. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. Am J Cardiol. 75:1995;1102-1106.
12. Neutel JM, Alderman M, Anders RJ, Weber MA. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning. Am Heart J. 132:1996;1202-1206.
13. Pickering TG, Levenstein M, Walmsley P. Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure: results of the HALT study. Am J Hypertens. 7:1994;844-847.
14. Canter DA, Texter MJ, McLain RW. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents. J Hypertens. 12:1994;S33-S38.
15. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 10:1997;261-268.
16. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 7:1994;23-29.
17. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Relationships between nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensives: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 27:1996;130-135.
18. Strandgaard S, Baulson OB. Cerebrovascular consequences of hypertension. Lancet. 344:1994;519-521.